GLPG
Price
$27.73
Change
-$0.23 (-0.82%)
Updated
Jun 6 closing price
Capitalization
1.85B
46 days until earnings call
IGMS
Price
$1.32
Change
+$0.08 (+6.45%)
Updated
Jun 6 closing price
Capitalization
74.84M
65 days until earnings call
Interact to see
Advertisement

GLPG vs IGMS

Header iconGLPG vs IGMS Comparison
Open Charts GLPG vs IGMSBanner chart's image
Galapagos
Price$27.73
Change-$0.23 (-0.82%)
Volume$419.56K
Capitalization1.85B
IGM Biosciences
Price$1.32
Change+$0.08 (+6.45%)
Volume$369.87K
Capitalization74.84M
GLPG vs IGMS Comparison Chart
Loading...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLPG vs. IGMS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLPG is a StrongBuy and IGMS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (GLPG: $27.73 vs. IGMS: $1.32)
Brand notoriety: GLPG and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLPG: 97% vs. IGMS: 210%
Market capitalization -- GLPG: $1.85B vs. IGMS: $74.84M
GLPG [@Biotechnology] is valued at $1.85B. IGMS’s [@Biotechnology] market capitalization is $74.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLPG’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • GLPG’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, GLPG is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLPG’s TA Score shows that 6 TA indicator(s) are bullish while IGMS’s TA Score has 5 bullish TA indicator(s).

  • GLPG’s TA Score: 6 bullish, 4 bearish.
  • IGMS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, GLPG is a better buy in the short-term than IGMS.

Price Growth

GLPG (@Biotechnology) experienced а -3.58% price change this week, while IGMS (@Biotechnology) price change was +3.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

GLPG is expected to report earnings on Jul 23, 2025.

IGMS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($1.85B) has a higher market cap than IGMS($74.8M). GLPG YTD gains are higher at: 0.836 vs. IGMS (-78.396). GLPG has higher annual earnings (EBITDA): -127.75M vs. IGMS (-199.47M). GLPG has more cash in the bank: 3.3B vs. IGMS (184M). GLPG has less debt than IGMS: GLPG (10.9M) vs IGMS (45.2M). GLPG has higher revenues than IGMS: GLPG (288M) vs IGMS (2.68M).
GLPGIGMSGLPG / IGMS
Capitalization1.85B74.8M2,479%
EBITDA-127.75M-199.47M64%
Gain YTD0.836-78.396-1%
P/E Ratio53.70N/A-
Revenue288M2.68M10,750%
Total Cash3.3B184M1,792%
Total Debt10.9M45.2M24%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
64
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLPGIGMS
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
60%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAVE221.5512.38
+5.92%
Dave
TFIN58.801.81
+3.18%
Triumph Financial
SHEL68.020.49
+0.73%
Shell plc
ROIV11.230.03
+0.27%
Roivant Sciences Ltd
SRZN8.50-0.14
-1.62%
Surrozen

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+6.45%
MRSN - IGMS
56%
Loosely correlated
+4.78%
DYN - IGMS
50%
Loosely correlated
+5.08%
CRNX - IGMS
48%
Loosely correlated
+2.13%
MDGL - IGMS
42%
Loosely correlated
+1.51%
ATXS - IGMS
41%
Loosely correlated
+14.75%
More